Stevanato group secures €130 million esg-linked financing from bnl bnp paribas and cassa depositi e prestiti to support sustainable global growth

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced two separate agreements with bnl bnp paribas and cassa depositi e prestiti group (cdp) to obtain esg-linked funds to support its ongoing global expansion.
STVN Ratings Summary
STVN Quant Ranking